Literature DB >> 17324813

Adaptation or selection? Old issues and new stakes in the postwar debates over bacterial drug resistance.

Angela N H Creager1.   

Abstract

The 1940s and 1950s were marked by intense debates over the origin of drug resistance in microbes. Bacteriologists had traditionally invoked the notions of 'training' and 'adaptation' to account for the ability of microbes to acquire new traits. As the field of bacterial genetics emerged, however, its participants rejected 'Lamarckian' views of microbial heredity, and offered statistical evidence that drug resistance resulted from the selection of random resistant mutants. Antibiotic resistance became a key issue among those disputing physiological (usually termed 'adaptationist') vs. genetic (mutation and selection) explanations of variation in bacteria. Postwar developments connected with the Lysenko affair gave this debate a new political valence. Proponents of the neo-Darwinian synthesis weighed in with support for the genetic theory. However, certain features of drug resistance seemed inexplicable by mutation and selection, particularly the phenomenon of 'multiple resistance'--the emergence of resistance in a single strain against several unrelated antibiotics. In the late 1950s, Tsutomu Watanabe and his collaborators solved this puzzle by determining that resistance could be conferred by cytoplasmic resistance factors rather than chromosomal mutation. These R factors could carry resistance to many antibiotics and seemed able to promote their own dissemination in bacterial populations. In the end, the vindication of the genetic view of drug resistance was accompanied by a recasting of the 'gene' to include extrachromosomal hereditary units carried on viruses and plasmids.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17324813     DOI: 10.1016/j.shpsc.2006.06.016

Source DB:  PubMed          Journal:  Stud Hist Philos Biol Biomed Sci        ISSN: 1369-8486


  11 in total

1.  Mutant bacteriophages, Frank Macfarlane Burnet, and the changing nature of "genespeak" in the 1930s.

Authors:  Neeraja Sankaran
Journal:  J Hist Biol       Date:  2010       Impact factor: 1.326

2.  The Bacterial Cell Wall in the Antibiotic Era: An Ontology in Transit Between Morphology and Metabolism, 1940s-1960s.

Authors:  María Jesús Santesmases
Journal:  J Hist Biol       Date:  2016-02       Impact factor: 1.326

3.  Bacterial Transformation and the Origins of Epidemics in the Interwar Period: The Epidemiological Significance of Fred Griffith's "Transforming Experiment".

Authors:  Pierre-Olivier Méthot
Journal:  J Hist Biol       Date:  2016-04       Impact factor: 1.326

4.  The Experimental Study of Bacterial Evolution and Its Implications for the Modern Synthesis of Evolutionary Biology.

Authors:  Maureen A O'Malley
Journal:  J Hist Biol       Date:  2018-06       Impact factor: 1.326

5.  Cancer, viruses, and mass migration: Paul Berg's venture into eukaryotic biology and the advent of recombinant DNA research and technology, 1967-1980.

Authors:  Doogab Yi
Journal:  J Hist Biol       Date:  2008       Impact factor: 1.326

6.  Malaria and quinine resistance: a medical and scientific issue between Brazil and Germany (1907-19).

Authors:  André Felipe Cândido da Silva; Jaime Larry Benchimol
Journal:  Med Hist       Date:  2014-01       Impact factor: 1.419

7.  Antibiotic Resistance and the Biology of History.

Authors:  Hannah Landecker
Journal:  Body Soc       Date:  2016-07-08

8.  Wars and sweets: microbes, medicines and other moderns in and beyond the(ir) antibiotic era.

Authors:  Coll Hutchison
Journal:  Med Humanit       Date:  2022-08-10

Review 9.  Acquired ABC-transporter overexpression in cancer cells: transcriptional induction or Darwinian selection?

Authors:  Dirk Theile; Pauline Wizgall
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-07-08       Impact factor: 3.000

Review 10.  What is a pathogen? Toward a process view of host-parasite interactions.

Authors:  Pierre-Olivier Méthot; Samuel Alizon
Journal:  Virulence       Date:  2014       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.